Company profile for Recursion Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Recursion is a clinical-stage biotechnology company leveraging artificial intelligence, machine learning, and large-scale biological data to transform drug discovery. Its proprietary platform analyzes cellular images and biological datasets to uncover disease mechanisms, identify novel therapeutic targets, and accelerate the development of innovative medicines. By integrating advanced AI with experimental biology, Recursion ai...
Recursion is a clinical-stage biotechnology company leveraging artificial intelligence, machine learning, and large-scale biological data to transform drug discovery. Its proprietary platform analyzes cellular images and biological datasets to uncover disease mechanisms, identify novel therapeutic targets, and accelerate the development of innovative medicines. By integrating advanced AI with experimental biology, Recursion aims to improve the speed, efficiency, and success rate of drug discovery, advancing potential treatments for cancer, rare diseases, and other areas of significant unmet medical need.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
41 S Rio Grande Street Salt Lake City, UT 84101
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

PEGS Boston Summit

PEGS Boston Summit

Not Confirmed

envelop Contact Supplier

PEGS Boston Summit

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/05/06/3288617/0/en/recursion-reports-first-quarter-financial-results-and-provides-business-update.html

GLOBENEWSWIRE
06 May 2026

https://www.globenewswire.com/news-release/2026/02/25/3244408/0/en/Recursion-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
25 Feb 2026

https://www.globenewswire.com/news-release/2025/12/08/3201434/0/en/Positive-Phase-1b-2-Results-from-Ongoing-REC-4881-TUPELO-Trial-Demonstrate-Rapid-and-Durable-Reductions-in-Polyp-Burden-in-Familial-Adenomatous-Polyposis-FAP-at-25-Weeks.html

GLOBENEWSWIRE
08 Dec 2025

https://www.globenewswire.com/news-release/2025/11/05/3181232/0/en/Recursion-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/08/05/3127144/0/en/Recursion-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Aug 2025

https://www.fiercebiotech.com/biotech/rallybio-shifts-gears-cashing-out-recursion-pact-extend-runway

FIERCE BIOTECH
08 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty